Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.1.1 Global Driver for Pharmaceutical Demand: 9
1.1.2 Pharmaceutical spending region wise 9
1.1.3 R&D pipeline in pharmaceutical industry 9
1.1.4 Top pharma drugs by sales in 2017 ($Million) 11
1.2 Industry Trends 12
1.3 Total Addressable Market 13
2 Report Outline 15
2.1 Report Scope 15
2.2 Report Summary 15
2.3 Research Methodology 16
2.4 Report Assumptions 16
3 Market Snapshot 18
3.1 Market Definition - Infoholic Research 18
3.2 Segmented Addressable Market (SAM) 18
3.3 Trends of Bacterial Conjunctivitis Drugs Market 19
3.4 Related Markets 20
3.4.1 Contact lenses 20
3.4.1.1 Trends of Contact Lens Market 21
3.4.2 Oncology (Cancer) Drugs 21
3.4.3 Active pharmaceutical ingredients (APIs) 22
3.4.4 Over the counter drugs (OTC) 22
4 Market Outline 23
4.1 Market Segmentation 23
4.2 Porter 5(Five) Forces 24
4.3 PEST Analysis 25
5 Market Characteristics 26
5.1 Market Dynamics of Bacterial Conjunctivitis Drugs Market 26
5.1.1 Drivers 27
5.1.1.1 Increasing awareness among patient population about pink eye disease 27
5.1.1.2 Rising prevalence of bacterial conjunctivitis 27
5.1.2 Opportunities 27
5.1.2.1 Increasing clinical trials 27
5.1.3 Restraints 28
5.1.3.1 Expiry of patents for blockbuster drugs 28
5.1.3.2 Complex drug development process 28
5.1.4 DRO - Impact Analysis 29
5.1.5 Key Stakeholders 29
6 Application: Market Size and Analysis 31
6.1 Overview 31
6.2 Fluoroquinolones 32
6.3 Aminoglycosides 33
6.4 Macrolides 34
6.5 Others 35
7 Regions: Market Size and Analysis 37
7.1 Overview 37
7.2 North America 38
7.2.1 Overview 38
7.3 Europe 39
7.3.1 Overview 39
7.4 APAC 41
7.4.1 Overview 41
7.5 Rest of the World 42
7.5.1 Overview 42
8 Competitive Landscape 44
9 Vendor Profiles 46
9.1 Novartis AG 46
9.1.1 Overview 46
9.1.2 Business Unit 51
9.1.3 Geographic Presence 51
9.1.4 Business Focus 52
9.1.5 SWOT Analysis 52
9.1.6 Business Strategy 53
9.2 Valeant Pharmaceuticals International Inc. 54
9.2.1 Overview 54
9.2.2 Business Unit 56
9.2.3 Geographic Presence 57
9.2.4 Business Focus 57
9.2.5 SWOT Analysis 58
9.2.6 Business Strategy 58
9.3 Teva Pharmaceutical Industries Ltd. 59
9.3.1 Overview 59
9.3.2 Business Unit 61
9.3.3 Geographic Presence 62
9.3.4 Business focus 63
9.3.5 SWOT analysis 63
9.3.6 Business Strategy 64
9.4 Akron Inc 64
9.4.1 Overview 64
9.4.2 Business Focus 67
9.4.3 SWOT Analysis 67
9.4.4 Business Strategy 68
10 Companies to Watch For 69
10.1 Santen Pharmaceutical Co.' Ltd. 69
10.1.1 Overview 69
10.2 Perrigo Company plc 70
10.2.1 Overview 70
10.3 Merck & Co. 71
10.3.1 Overview 71
10.4 Pfizer Inc.' 72
10.4.1 Overview 72
10.4.2 Highlights 74
10.5 Daiichi Sankyo' Inc. 74
10.5.1 Overview 74
10.5.2 Overview 75
10.6 Bayer AG 75
10.6.1 Overview 75
10.7 F. Hoffmann-La Roche 76
10.7.1 Overview 76
Annexure 80
Abbreviations 80